Man, Mosquito, Malaria Vaccine
The a16z Show2 Mai 2021

Man, Mosquito, Malaria Vaccine

Playing out against the backdrop of a global pandemic (including recent massive surges in regions around the world) is the news that came out a week ago that a candidate "malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal”. While the findings are still in preprint with The Lancet, the resulting buzz and phrases quoted included everything from “unprecedented”, “groundbreaking work”, and “very exciting” to “high expectations”, “highly effective”, and “a hugely significant extra weapon”... A "weapon" in the war against malaria that is -- a disease that is estimated to cause over 400,000 deaths each year globally, and predominantly in children under the age of five.

So in this special 2x explainer episode of 16 Minutes (also running on the a16z Podcast), we -- Rajeev Venkayya of Takeda Pharmaceuticals, a16z bio general partner Jorge Conde, and Sonal Chokshi -- dig into what's hype/ what's real about this news, beyond the headlines and beyond the buzz. What does the data tell us, what does the current study phase mean, and what's left to get to widespread, real-world use? How does this candidate vaccine (R21 from Jenner Institute/ Oxford University) compare to the other malaria vaccine (RTS,S from GlaxoSmithKline)? How do, and don't, advances in and around COVID vaccines play here? And why has it been so hard to develop vaccines for this particular disease?

Because we also cover (as is the premise of the show) where we are on the long arc of innovation... and this is an innovation story that's been nearly a century in the making.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

Why AI Voice Feels More Human Than Ever

Why AI Voice Feels More Human Than Ever

AI voice technology has been around for years — think Siri or Alexa — but the magic has been missing. That’s changing, and quickly!In this episode, Anish Acharya, General Partner at a16z, and Olivia M...

18 Mar 202543min

From Thesis to Meme to Fund: Building American Dynamism

From Thesis to Meme to Fund: Building American Dynamism

For over a century, the United States has been the birthplace of world-changing innovation – from the Wright brothers’ first flight to the invention of the transistor, the moon landing, and the birth ...

11 Mar 202542min

What Founders Get Wrong About Scaling – With Carta’s CEO

What Founders Get Wrong About Scaling – With Carta’s CEO

Henry Ward, cofounder and CEO of Carta, has spent over a decade scaling his company from an early-stage startup to a 2,000-person industry leader. In this a16z Speedrun conversation with Games partner...

7 Mar 202540min

Creativity vs Control: Where AI Fits in the Creative Toolbox

Creativity vs Control: Where AI Fits in the Creative Toolbox

Being a creator in 2025 is tough—but building for creators is even harder. Perhaps no one understands this conundrum better than Scott Belsky. As the founder of Behance, a longtime executive at Adobe,...

25 Feb 202542min

Who Will Own the Internet? a16z’s Chris Dixon on AI and Crypto

Who Will Own the Internet? a16z’s Chris Dixon on AI and Crypto

Technology doesn’t grow in isolation—it evolves in waves. Just as mobile, cloud, and SaaS shaped the internet of the past 20 years, so too could crypto, AI, and new hardware usher in an era of the int...

20 Feb 202532min

The Critical Technology in Finding Critical Materials

The Critical Technology in Finding Critical Materials

Critical materials like copper, lithium, and gallium have been mined for decades, but their role in core technologies, geopolitics, and the energy transition have come to a height in recent years.In t...

11 Feb 202542min

DeepSeek: America’s Sputnik Moment for AI?

DeepSeek: America’s Sputnik Moment for AI?

Two words have caught the Internet by storm. DeepSeek. The Chinese reasoning model r1 is rivaling others at the frontier with an open-source MIT license, methods that some claim may be 45x more effici...

6 Feb 202543min

Ben Horowitz Sharing History with Dr. Clarence Jones, MLK's Speechwriter

Ben Horowitz Sharing History with Dr. Clarence Jones, MLK's Speechwriter

This week, a16z cofounder Ben Horowitz had a rare and invaluable conversation with Dr. Clarence B. Jones, a pivotal figure in American history. Dr. Jones, who served as speechwriter, attorney, and adv...

1 Feb 202555min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
livet-pa-veien-med-jan-erik-larssen
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
finansredaksjonen
utbytte
pengepodden-2
rss-sunn-okonomi
morgenkaffen-med-finansavisen
lederpodden
stormkast-med-valebrokk-stordalen
liberal-halvtime
rss-markedspuls-2
lederskap-nhhs-podkast-om-ledelse
arcticpodden